Aviceda Therapeutics

Aviceda Therapeutics is a private, late-stage clinical biotechnology company based in Cambridge, Massachusetts that describes itself as the world leader in glyco-immune checkpoint therapeutics. It develops immune-mediated therapies built on a glyco-mimetic nanoparticle platform that targets the interaction between sialic acids on cell surfaces and Siglec immune receptors in order to modulate aberrant inflammation. Its lead asset, AVD-104, is an intravitreally administered sialic-acid-coated nanoparticle being evaluated in the Phase 2/3 SIGLEC trial for geographic atrophy secondary to age-related macular degeneration. Aviceda is a therapeutics developer, not a software vendor: it publishes no developer program, no public API, and no machine-readable API artifacts.

Aviceda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Therapeutics, and Ophthalmology.

Aviceda Therapeutics’ developer surface includes product news and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyPharmaceuticalsTherapeuticsOphthalmologyClinical TrialsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 5.4/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/aviceda-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Company 7

The organization behind the API

Website

About

Careers

News

Investors

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 1

Properties that don't map to a standard resource type

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: aviceda-therapeutics
name: Aviceda Therapeutics
description: 'Aviceda Therapeutics is a private, late-stage clinical biotechnology company based in Cambridge, Massachusetts
  that describes itself as the world leader in glyco-immune checkpoint therapeutics. It develops immune-mediated therapies
  built on a glyco-mimetic nanoparticle platform that targets the interaction between sialic acids on cell surfaces and Siglec
  immune receptors in order to modulate aberrant inflammation. Its lead asset, AVD-104, is an intravitreally administered
  sialic-acid-coated nanoparticle being evaluated in the Phase 2/3 SIGLEC trial for geographic atrophy secondary to age-related
  macular degeneration. Aviceda is a therapeutics developer, not a software vendor: it publishes no developer program, no
  public API, and no machine-readable API artifacts.'
url: https://raw.githubusercontent.com/api-evangelist/aviceda-therapeutics/refs/heads/main/apis.yml
image: https://www.avicedarx.com/media/logo/aviceda.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Therapeutics
- Ophthalmology
- Clinical Trials
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/aviceda-therapeutics-domain-security.yml
- type: Website
  url: https://www.avicedarx.com/
- type: About
  url: https://www.avicedarx.com/about-us
- type: Contact
  url: https://www.avicedarx.com/contact
- type: Careers
  url: https://www.avicedarx.com/careers
- type: News
  url: https://www.avicedarx.com/company-updates
- type: Investors
  url: https://www.avicedarx.com/investors
- type: LinkedIn
  url: https://www.linkedin.com/company/aviceda-therapeutics/
- type: Twitter
  url: https://twitter.com/avicedarx
- type: SecondaryMarket
  url: https://forgeglobal.com/aviceda-therapeutics_stock/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Aviceda is a clinical-stage biotech developing the AVD-104 nanoparticle for geographic atrophy; its entire web presence
    is a ten-page corporate brochure at avicedarx.com (sitemap.xml lists only home, technology-platform, lead-asset, pipeline,
    publications, company-updates, about-us, investors, careers, contact) with no developer section, and api./developer./docs.avicedarx.com
    do not resolve in DNS.
  evidence:
  - url: https://www.avicedarx.com/sitemap.xml
    status: 200
  - url: https://www.avicedarx.com/openapi.json
    status: 404
  - url: https://www.avicedarx.com/.well-known/agent-card.json
    status: 404
  checked: '2026-08-06'